Safety, Tolerability and Pharmacokinetics of GSK1034702 in Healthy Subjects

Clinical trial NCT00743405 · COMPLETED

Trial details

NCT number: NCT00743405
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cognitive Disorders

Start date: 2008-05-02
Primary completion: 2008-12-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.